Therefore, these results explain the underlying mechanisms of lower CRMP2 in CRC-DM patients and the correlation between CRC disease progression and diabetic onset in CRC-DM subjects (Table 2). The gene discussed is DPYSL2; the disease is colorectal carcinoma.